Latest Pharmaceutics Stories
DUBLIN, April 15, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dwz9l5/pharmacovigilance) has announced the addition of the "Pharmacovigilance
CUPERTINO, Calif., March 30, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928,
- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances R&D technology portfolio of Merck KGaA, Darmstadt, Germany, in immuno-oncology DARMSTADT, Germany, March 30, 2015 /PRNewswire/
Ale Gicqueau, Founder and President of Clinovo, presents on “Conducting Postmarket Registries - Rationale and Execution” at the ACRP 2015
NeoStrata to take part in the 2015 edition of the Lolë White Tour(TM) across Canada MONTREAL, March 25, 2015 /CNW Telbec/ - Canadian cosmeceutical brand
SEATTLE and BERKELEY, Calif.
COSTA MESA, Calif., March 13, 2015 /PRNewswire-iReach/ -- WCCT Global, a full-service contract research organization (CRO) based
-- Collaboration strengthens company's position as a leader in precision medicine in oncology ROCKLAND, Mass., March 10, 2015 /PRNewswire/ -- EMD Serono today announced that the biopharmaceutical
DALLAS and NEW YORK, March 10, 2015 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
DUBLIN, March 9, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it has launched a generic version of Fougera's Temovate(®)
- Growing in low tufty patches.